Children with cancer ‘denied drugs because of EU rules’ (BBC News, 11 February 2014)

11 Feb 2014


The UK’s Institute of Cancer Research has called for a change in EU regulations that allow pharmaceutical companies to opt out of clinical trials for children if a new drug is intended for an adult cancer that does not occur in children.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story